From enemy
to hero.
Watch the video and discover how Vyro is transforming the scourge of the Zika virus into revolutionary treatments.
Pipeline
About us
Our team is made up of professionals specialized in several areas who have the same mission: to create innovative treatments for the greatest challenges of human health.
We invite you to learn more about our team and see who is behind our success and efficiency.
Board of Directors
JORGE KALIL
Member of the Board of Directors
Full Professor and Head of Clinical Immunology and Allergy at Medical School - University of São Paulo. Member of the Brazilian Academy of Sciences since 1995. He was director of the Butantan Institute, the largest vaccine manufacturer in Brazil, for six years (2011-2017). He is Doctor Honoris Causa by the Sorbonne Universités, Paris, and by the Federal University of Rio Grande do Sul and Fellow of the Royal College of Physicians London FRCP. In 2022 he was ...
JORGE KALIL
Member of the Board of Directors
Full Professor and Head of Clinical Immunology and Allergy at Medical School - University of São Paulo. Member of the Brazilian Academy of Sciences since 1995. He was director of the Butantan Institute, the largest vaccine manufacturer in Brazil, for six years (2011-2017). He is Doctor Honoris Causa by the Sorbonne Universités, Paris, and by the Federal University of Rio Grande do Sul and Fellow of the Royal College of Physicians London FRCP. In 2022 he was elected Full Member of the National Academy of Medicine and Academic of the Lebanese-Brazilian Academy of Letters, Arts and Sciences.
KEITH OKAMOTO
Cofounder and Board Member
Full Professor at the University of Sao Paulo (USP) and Principal Researcher at The Human Genome and Stem Cell Research Center (HUG-CELL) at USP, where he directs the Translational Genomics Laboratory since 2010. Using a multidisciplinary approach, his research has contributed to a better understanding of the molecular mechanisms that regulate stem cell self-renewal, differentiation, and contribution to the development of cancer.
GABRIEL BOTTOS
Member of the Board of Directors
Gabriel graduated in production engineering at the University of Santa Catarina. Co-founder and CEO at Vesper Ventures SA, a biotech venture builder fund, where he participates at the board of several startups focused on therapies, diagnostics, agriculture and environment. Previously he co-founded companies such as Welle Laser SA, Exact Sales and GnTech. He is a member of Endeavor and Board of Trustees member at the Fraunhofer Project Center for Advanced Man...
GABRIEL BOTTOS
Member of the Board of Directors
Gabriel graduated in production engineering at the University of Santa Catarina. Co-founder and CEO at Vesper Ventures SA, a biotech venture builder fund, where he participates at the board of several startups focused on therapies, diagnostics, agriculture and environment. Previously he co-founded companies such as Welle Laser SA, Exact Sales and GnTech. He is a member of Endeavor and Board of Trustees member at the Fraunhofer Project Center for Advanced Manufacturing @ ITA.
Scientific Advisory Board
MARCIA DE SOUZA LIMA
Scientific Advisor
Marcia is an ophthalmologist with extensive experience in medical affairs and clinical development programs in the USA, Europe, and other global regions. More recently, she held the positions of Global Medical Affairs Head, Ophthalmology at Shire/Takeda Pharmaceuticals, Chief Medical Officer at Oculis SA, and Head, Medical Affairs of the Cell and Gene therapy business unit at Santen Pharmaceuticals. She has worked with startups and big pharmaceutical compani...
MARCIA DE SOUZA LIMA
Scientific Advisor
Marcia is an ophthalmologist with extensive experience in medical affairs and clinical development programs in the USA, Europe, and other global regions. More recently, she held the positions of Global Medical Affairs Head, Ophthalmology at Shire/Takeda Pharmaceuticals, Chief Medical Officer at Oculis SA, and Head, Medical Affairs of the Cell and Gene therapy business unit at Santen Pharmaceuticals. She has worked with startups and big pharmaceutical companies, such as Novartis and Pfizer, in roles ranging from medical and clinical research expert to senior executive leader. She has managed global teams of up to 100 employees, and her experience includes working on pharmaceutical, biologics, and device programs. Marcia received her medical degree from the Federal University of Minas Gerais, Brazil, and furthered her clinical research studies at the Shiley Eye Center, University of California, San Diego. She holds a Master of International Public Policy from Johns Hopkins University and is a candidate for the Executive Global Master in Management at the London School of Economics.
HARRY BULSTRODE
Scientific Advisor
Harry Bulstrode FRCS PhD is a Clinician Scientist and Consultant neurosurgeon at Addenbrooke’s Hospital, specialising in stereotactic and functional surgery. His lab at the Wellcome MRC Cambridge Stem Cell Institute (University of Cambridge) studies neural stem cells and their microenvironment interactions in brain development, cancer and neurodegeneration.
MAYANA ZATZ
Co-founder and Scientific Advisor
Mayana Zatz is a Brazilian molecular biologist and geneticist, professor at the Department of Genetics and Evolutionary Biology at the Institute of Biosciences at the University of Sao Paulo (USP). She held the position of Dean of Research at USP from 2005 to 2009. Researcher in human genetics with contributions mainly in the field of neuromuscular diseases (muscular dystrophies, spastic paraplegias, amyotrophic lateral ese) in which she is a pioneer. Cu...
MAYANA ZATZ
Co-founder and Scientific Advisor
Mayana Zatz is a Brazilian molecular biologist and geneticist, professor at the Department of Genetics and Evolutionary Biology at the Institute of Biosciences at the University of Sao Paulo (USP). She held the position of Dean of Research at USP from 2005 to 2009. Researcher in human genetics with contributions mainly in the field of neuromuscular diseases (muscular dystrophies, spastic paraplegias, amyotrophic lateral ese) in which she is a pioneer. Currently, her Human Genome Laboratory at USP also conducts research in the field of stem cells.
Team
CAROLINI KAID, PHD
Cofounder and Chief Scientific Officer
Completing 10 years of research experience in the field of cancer biology and genetics. Graduated in Biological Sciences from the University of Sao Paulo (2012). She was the first author of the two breakthrough publications on preclinical studies with the oncolytic Zika virus. She continues to investigate alternative immunotherapies focusing on oncolytic viruses.
MAURICIO MEROS
Chief of Operations
Mauricio Meros has a degree in Chemical Engineering, He has a 24 years of pharmaceutical and biological manufacturing, development, process and engineering, Former Director of the Division of Technological Development and Production of Instituto Butantan where he was also Director of the Division of Engineering and Architecture, President of the Brazilian Society of Contamination Control [SBCC].
GABRIELA NOVAES, PHD
Scientist, Oncology
Gabriela Novaes received her PhD from the school of Pharmaceutical Sciences at the University of Sao Paulo. She is specialized in molecular oncology with a focus in microRNAs. Currently, Gabriela is the scientist responsible for preclinical in vitro tests that guarantee the safety and effectiveness of the products developed by Vyro Biotherapeutics.
GIOVANNA OLBERG, B.SC
Lab technician, Cell Biology
Giovanna Olberg, Biologist with a postgraduate degree in Health Services Management, has experience in Cell Biology, Molecular Biology and Human Genetics from the Human Genome and Stem Cell Research Center (HUG-CELL) of the University of Sao Paulo. At Vyro Biotherapeutics, she’s responsible for maintaining cell culture.
PEDRO MACHADO
Scientist, Vector Engineering, Biotechnologist
Pedro is responsible for the creation and development of strategies for gene therapy vectors employing the Zika virus. He’s also responsible for the execution of the oncolytic virus platform. Pedro graduated from the Federal University of Uberlandia with a bachelor's degree in biotechnology. He completed his scientific initiation in the fields of biochemistry, bioprocesses, and fermentative processes. While on exchange in Portugal, he worked as a researcher ...
PEDRO MACHADO
Scientist, Vector Engineering, Biotechnologist
Pedro is responsible for the creation and development of strategies for gene therapy vectors employing the Zika virus. He’s also responsible for the execution of the oncolytic virus platform. Pedro graduated from the Federal University of Uberlandia with a bachelor's degree in biotechnology. He completed his scientific initiation in the fields of biochemistry, bioprocesses, and fermentative processes. While on exchange in Portugal, he worked as a researcher at the University of Minho's Center for Biological Engineering, where he focused on the development of bioproducts. He was an intern at the Butantan Institute's genetics laboratory, working with human papillomavirus (HPV) and bovine papillomavirus (BPV). He's a master's degree student at the University of Sao Paulo working on the development of an epitope-based vaccine against the human papillomavirus (HPV) and the SARS-CoV-2 at Butantan Institute.
DIEGO MODOLO, PHD
Scientist, Gene Therapy Vector Engineering
Diego Grando Modolo graduated in Biological Sciences and has a master’s degree and PhD in Genetics and Molecular Biology from State University of Campinas (UNICAMP). Diego has more than 17 years of experience in DNA vector design and recombinant protein expression, purification, and characterization. Since graduating, Diego has worked in DNA vector design and the production of recombinant proteins in plants and bacteria. As a Postdoctoral Researcher, Diego ...
DIEGO MODOLO, PHD
Scientist, Gene Therapy Vector Engineering
Diego Grando Modolo graduated in Biological Sciences and has a master’s degree and PhD in Genetics and Molecular Biology from State University of Campinas (UNICAMP). Diego has more than 17 years of experience in DNA vector design and recombinant protein expression, purification, and characterization. Since graduating, Diego has worked in DNA vector design and the production of recombinant proteins in plants and bacteria. As a Postdoctoral Researcher, Diego collaborated in the development of a vaccine for human papillomavirus (HPV) using combinatory strategies for protein design and vector design for recombinant expression of modified antigens. Furthermore, he collaborated with the development of a bacterial vector for the delivery of the p53 gene to human bladder carcinoma cells. Currently, he's a Gene Therapy Vector Engineer at Vyro Biotherapeutics focusing on the development of a Zika virus viral vector for the delivery of gene therapies for neurological diseases.
CARLA LONGO, PHD
Scientist, Virology & Immunology
Carla Longo is a biologist graduated from the Federal University of Sao Paulo (UNIFESP), has a master's degree in Immunology from the same University, and doctorate degree in Immunology from the University of Sao Paulo. During her PhD, Carla studied neuro immunology and investigated how Zika virus infection impacts central nervous system development and causes severe neurological diseases. She also participated in studies with dengue virus. Then, she conduct...
CARLA LONGO, PHD
Scientist, Virology & Immunology
Carla Longo is a biologist graduated from the Federal University of Sao Paulo (UNIFESP), has a master's degree in Immunology from the same University, and doctorate degree in Immunology from the University of Sao Paulo. During her PhD, Carla studied neuro immunology and investigated how Zika virus infection impacts central nervous system development and causes severe neurological diseases. She also participated in studies with dengue virus. Then, she conducted her postdoctoral fellowship at UNIFESP in the Department of Medicine, where she continues to study viral infection and antiviral therapies."
THAIS PERON
Scientist, Quality
Thais Peron has a master degree at the Institute of Biomedical Sciences at the University of Sao Paulo, where she specialized in Plasmodium molecular genetics, with focus in drug discovery. Currently, Thais is the scientist responsible for quality management, assuring the excellence of the processes and products produced by Vyro Biotherapeutics.
CAROLINE LIMA, MSC
Scientist, Molecular Biology
Caroline Lima, graduate in biomedicine and master’s degree in biotechnology with an emphasis on bioproducts and bioprocesses from the Federal University of Sao Paulo (UNIFESP). Her career began in scientific initiation during graduation, where she worked with cloning, expression of heterologous proteins and other recombinant DNA technologies. During her master's degree, she worked with conditional gene expression and IC50 methodologies. Currently, Caroline i...
CAROLINE LIMA, MSC
Scientist, Molecular Biology
Caroline Lima, graduate in biomedicine and master’s degree in biotechnology with an emphasis on bioproducts and bioprocesses from the Federal University of Sao Paulo (UNIFESP). Her career began in scientific initiation during graduation, where she worked with cloning, expression of heterologous proteins and other recombinant DNA technologies. During her master's degree, she worked with conditional gene expression and IC50 methodologies. Currently, Caroline is head of molecular biology at Vyro Biotherapeutics, responsible for the entire process from cloning strategy to sequencing.
PATRICIA CALDERON
Public Relations (PR)
Journalist, businesswoman, and TV presenter. She has worked in major communication Brazilian companies such as Editora Abril, Folha de São Paulo, Rede TV, SBT, Record TV, and UOL. She is currently a presenter at Jovem Pan. Performs press office service in the areas of hospitality, tourism, gastronomy, sports, and health. Works with the planning and management of online and printed content and maintains a good part of its work dedicated to television journali...
PATRICIA CALDERON
Public Relations (PR)
Journalist, businesswoman, and TV presenter. She has worked in major communication Brazilian companies such as Editora Abril, Folha de São Paulo, Rede TV, SBT, Record TV, and UOL. She is currently a presenter at Jovem Pan. Performs press office service in the areas of hospitality, tourism, gastronomy, sports, and health. Works with the planning and management of online and printed content and maintains a good part of its work dedicated to television journalism and communication and public relations assistance.
FLÁVIA SANTORO
Marketing assistant
Biomedical Sciences undergraduate student at the Institute of Biomedical Sciences of the University of Sao Paulo (ICB/USP). Co-founder of the Instagram account @ocienciaetal and co-founder of the 1st League of Scientific Communication at USP. Lecturer on immunology in 2 editions of USP-Escola, in 2021 and 2022. She is currently a marketing assistant at Vyro Biotherapeutics.
